• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Meta-Analysis Evaluating the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction According to Baseline Anemia.

作者信息

Patoulias Dimitrios, Papadopoulos Christodoulos, Fragakis Nikolaos, Karagiannis Asterios, Doumas Michael

机构信息

Second Propaedeutic Department of Internal Medicine.

Third Department of Cardiology, Aristotle University of Thessaloniki, General Hospital "Hippokration," Thessaloniki, Greece.

出版信息

Am J Cardiol. 2022 Sep 15;179:111-114. doi: 10.1016/j.amjcard.2022.06.011. Epub 2022 Jul 22.

DOI:10.1016/j.amjcard.2022.06.011
PMID:35871863
Abstract
摘要

相似文献

1
Meta-Analysis Evaluating the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction According to Baseline Anemia.根据基线贫血情况评估钠-葡萄糖协同转运蛋白2抑制剂对射血分数降低的心力衰竭患者心血管疗效的Meta分析
Am J Cardiol. 2022 Sep 15;179:111-114. doi: 10.1016/j.amjcard.2022.06.011. Epub 2022 Jul 22.
2
Sodium glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: a systematic review and meta-analysis.射血分数保留的心力衰竭中钠-葡萄糖协同转运蛋白2抑制剂：一项系统评价和荟萃分析。
Eur J Prev Cardiol. 2022 May 6;29(6):e227-e229. doi: 10.1093/eurjpc/zwab189.
3
Pharmacology Focus: Clinical Evidence for the Use of Sodium-Glucose Co-transporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction.药理学聚焦：钠-葡萄糖协同转运蛋白2抑制剂用于射血分数保留的心力衰竭的临床证据
S D Med. 2022 Jul;75(7):328-329.
4
Another brick in the wall of cardioprotection? A meta-analysis addressing the effect of sodium-glucose co-transporter 2 inhibitors on left ventricular mass assessed by cardiovascular magnetic resonance in patients with heart failure with reduced ejection fraction.
J Cardiovasc Med (Hagerstown). 2022 Aug 1;23(8):570-572. doi: 10.2459/JCM.0000000000001328.
5
[Serendipity of sodium-glucose co-transporter 2 inhibitors: a new paradigm in the management of heart failure with reduced ejection fraction].[钠-葡萄糖协同转运蛋白2抑制剂的意外收获：射血分数降低的心力衰竭管理新范式]
G Ital Cardiol (Rome). 2021 Apr;22(4):277-283. doi: 10.1714/3574.35573.
6
Sodium-glucose co-transporter 2 inhibitors: drugs with multiple effects, but which one is relevant to heart failure with preserved ejection fraction? Letter regarding the article 'Early benefit with empagliflozin in heart failure with preserved ejection fraction: insights from the EMPEROR-Preserved trial'.钠-葡萄糖协同转运蛋白2抑制剂：具有多种作用的药物，但哪一种与射血分数保留的心力衰竭相关？关于文章《恩格列净对射血分数保留的心力衰竭的早期获益：EMPEROR-Preserved试验的见解》的信函
Eur J Heart Fail. 2022 Jul;24(7):1323-1324. doi: 10.1002/ejhf.2466. Epub 2022 Mar 9.
7
A mechanistic rationale for the investigation of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction. Letter regarding the article 'Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial'.对射血分数保留的心力衰竭患者进行钠-葡萄糖协同转运蛋白2抑制剂研究的机制原理。关于文章“EMPEROR-Preserved试验中射血分数保留的心力衰竭患者的基线特征”的信函
Eur J Heart Fail. 2021 May;23(5):841. doi: 10.1002/ejhf.2091. Epub 2021 Feb 4.
8
Sodium-glucose co-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fraction.钠-葡萄糖共转运蛋白 2 抑制剂在射血分数降低的心力衰竭患者中的适用性。
Int J Cardiol. 2021 Oct 15;341:56-59. doi: 10.1016/j.ijcard.2021.08.035. Epub 2021 Aug 26.
9
Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology.钠-葡萄糖协同转运蛋白 2 抑制剂在心力衰竭中的应用：超越血糖控制。欧洲心脏病学会心力衰竭协会立场文件。
Eur J Heart Fail. 2020 Sep;22(9):1495-1503. doi: 10.1002/ejhf.1954. Epub 2020 Aug 5.
10
Meta-Analysis Evaluating the Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Acute or Recently Decompensated Heart Failure.
Am J Cardiol. 2022 Jun 1;172:171-172. doi: 10.1016/j.amjcard.2022.03.010. Epub 2022 Apr 5.